Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)

SHA:688739 Revenue

Liaoning Chengda Biotechnology had revenue of 273.35M CNY in the quarter ending March 31, 2026, a decrease of -23.73%. This brings the company's revenue in the last twelve months to 1.31B, down -21.84% year-over-year. In the year 2025, Liaoning Chengda Biotechnology had annual revenue of 1.39B, down -17.06%.

• Revenue (ttm): 1.31B
• Revenue Growth: -21.84%
• P/S Ratio: 6.52
• Revenue / Employee: 732.87K
• Employees: 1,781
• Market Cap: 8.50B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.39B	-285.95M	-17.06%
Dec 31, 2024	1.68B	-73.86M	-4.22%
Dec 31, 2023	1.75B	-64.90M	-3.58%
Dec 31, 2022	1.81B	-273.04M	-13.08%
Dec 31, 2021	2.09B	92.47M	4.63%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error